Helping transform medical discovery and innovation into viable solutions that can impact the world
HALTERES' MAIN FOCUS AREAS
Maximizing Value
Understanding market needs. Learn More »»
Portfolio Planning
Balancing technical difficulty of development with commercial attractiveness. Learn More »»
Informatics in Molecular Medicine
The use of multi-methodology algorithms in medical practice today. Learn More »»
The Role of Impact Modeling
Establishing the “value” in high-value diagnostics. Learn More »»
Delivering Diagnostics for Global Health
Understanding needs and developing diagnostic solutions that improve linkage to care in low resource settings. Learn More »»
Point of Care Testing
Renewed interest in decentralized or Point of Care Testing: what’s changed?. Learn More »»
Consumer Digital and Mobile Health
Understanding regulatory, payment and education challenges in the consumer digital health space. Learn More »»
Latest News
Dr. Mickey S. Urdea and Mr. Rich Thayer will attend the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California. The JPM Healthcare Conference continues their tradition of hosting the largest and most informative healthcare investment symposium in the industry. In 2019, more than 450 companies, both public and private, are set to deliver presentations to more than 9,000 attendees.
HALTERES' CORE COMPETENCIES
Services
- Business and Financial Modeling
- Business Development
- Clinical Studies and Regulatory
- Global Sales and Marketing
- Impact Modeling and Value Creation
- Intellectual Property
- Investor Presentations
- Market and Technology Assessments
- Medical Practice
- Portfolio Planning
- Product and Process Development
- Strategic and Tactical Planning
Technologies
- Algorithms / Informatics / Health IT
- Biomarker Discovery and Validation
- Biostatistics
- Companion Diagnostics
- Digital Health and Wellness
- Histology / Anatomic and Clinical Pathology
- Immunodiagnostics
- Instrument Systems
- Life Science Research Tools
- Medical Devices
- Molecular Diagnostics
- Next Generation Sequencing
Markets
- Blood Screening
- Chronic Diseases
- Clinical Laboratory Services
- Global Health
- Infectious and Chronic Diseases
- Life Science Research
- Oncology
- “Omics” applications
- Parasitology
- Pathology
- Point of Care Testing